<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d396" origId="Exemestane"><sentence id="DrugDDI.d396.s0" origId="s0" text="Exemestane is extensively metabolized by CYP 3A4, but coadministration of ketoconazole, a potent inhibitor of CYP 3A4, has no significant effect on exemestane pharmacokinetics."><entity id="DrugDDI.d396.s0.e0" origId="s0.p0" charOffset="0-10" type="drug" text="Exemestane"/><entity id="DrugDDI.d396.s0.e1" origId="s0.p4" charOffset="41-44" type="drug" text="CYP"/><entity id="DrugDDI.d396.s0.e2" origId="s0.p7" charOffset="74-86" type="drug" text="ketoconazole"/><entity id="DrugDDI.d396.s0.e3" origId="s0.p9" charOffset="110-113" type="drug" text="CYP"/><entity id="DrugDDI.d396.s0.e4" origId="s0.p12" charOffset="148-158" type="drug" text="exemestane"/><pair id="DrugDDI.d396.s0.p0" e1="DrugDDI.d396.s0.e0" e2="DrugDDI.d396.s0.e1" interaction="false"/><pair id="DrugDDI.d396.s0.p1" e1="DrugDDI.d396.s0.e0" e2="DrugDDI.d396.s0.e2" interaction="false"/><pair id="DrugDDI.d396.s0.p2" e1="DrugDDI.d396.s0.e0" e2="DrugDDI.d396.s0.e3" interaction="false"/><pair id="DrugDDI.d396.s0.p3" e1="DrugDDI.d396.s0.e0" e2="DrugDDI.d396.s0.e4" interaction="false"/><pair id="DrugDDI.d396.s0.p4" e1="DrugDDI.d396.s0.e1" e2="DrugDDI.d396.s0.e2" interaction="false"/><pair id="DrugDDI.d396.s0.p5" e1="DrugDDI.d396.s0.e1" e2="DrugDDI.d396.s0.e3" interaction="false"/><pair id="DrugDDI.d396.s0.p6" e1="DrugDDI.d396.s0.e1" e2="DrugDDI.d396.s0.e4" interaction="false"/><pair id="DrugDDI.d396.s0.p7" e1="DrugDDI.d396.s0.e2" e2="DrugDDI.d396.s0.e3" interaction="false"/><pair id="DrugDDI.d396.s0.p8" e1="DrugDDI.d396.s0.e2" e2="DrugDDI.d396.s0.e4" interaction="false"/><pair id="DrugDDI.d396.s0.p9" e1="DrugDDI.d396.s0.e3" e2="DrugDDI.d396.s0.e4" interaction="false"/></sentence><sentence id="DrugDDI.d396.s1" origId="s1" text="Significant pharmacokinetic interactions mediated by inhibition of CYP isoenzymes therefore appear unlikely."><entity id="DrugDDI.d396.s1.e0" origId="s1.p16" charOffset="71-81" type="drug" text="isoenzymes"/></sentence><sentence id="DrugDDI.d396.s2" origId="s2" text="Co-medications that induce CYP 3A4 (e.g., rifampicin, phenytoin, carbamazepine, phenobarbital, or St. John?s wort) may significantly decrease exposure to exemestane."><entity id="DrugDDI.d396.s2.e0" origId="s2.p19" charOffset="3-14" type="drug" text="medications"/><entity id="DrugDDI.d396.s2.e1" origId="s2.p22" charOffset="27-30" type="drug" text="CYP"/><entity id="DrugDDI.d396.s2.e2" origId="s2.p25" charOffset="42-52" type="drug" text="rifampicin"/><entity id="DrugDDI.d396.s2.e3" origId="s2.p26" charOffset="54-63" type="drug" text="phenytoin"/><entity id="DrugDDI.d396.s2.e4" origId="s2.p27" charOffset="65-78" type="drug" text="carbamazepine"/><entity id="DrugDDI.d396.s2.e5" origId="s2.p28" charOffset="80-93" type="drug" text="phenobarbital"/><entity id="DrugDDI.d396.s2.e6" origId="s2.p34" charOffset="154-164" type="drug" text="exemestane"/><pair id="DrugDDI.d396.s2.p0" e1="DrugDDI.d396.s2.e0" e2="DrugDDI.d396.s2.e1" interaction="false"/><pair id="DrugDDI.d396.s2.p1" e1="DrugDDI.d396.s2.e0" e2="DrugDDI.d396.s2.e2" interaction="false"/><pair id="DrugDDI.d396.s2.p2" e1="DrugDDI.d396.s2.e0" e2="DrugDDI.d396.s2.e3" interaction="false"/><pair id="DrugDDI.d396.s2.p3" e1="DrugDDI.d396.s2.e0" e2="DrugDDI.d396.s2.e4" interaction="false"/><pair id="DrugDDI.d396.s2.p4" e1="DrugDDI.d396.s2.e0" e2="DrugDDI.d396.s2.e5" interaction="false"/><pair id="DrugDDI.d396.s2.p5" e1="DrugDDI.d396.s2.e0" e2="DrugDDI.d396.s2.e6" interaction="false"/><pair id="DrugDDI.d396.s2.p6" e1="DrugDDI.d396.s2.e1" e2="DrugDDI.d396.s2.e2" interaction="false"/><pair id="DrugDDI.d396.s2.p7" e1="DrugDDI.d396.s2.e1" e2="DrugDDI.d396.s2.e3" interaction="false"/><pair id="DrugDDI.d396.s2.p8" e1="DrugDDI.d396.s2.e1" e2="DrugDDI.d396.s2.e4" interaction="false"/><pair id="DrugDDI.d396.s2.p9" e1="DrugDDI.d396.s2.e1" e2="DrugDDI.d396.s2.e5" interaction="false"/><pair id="DrugDDI.d396.s2.p10" e1="DrugDDI.d396.s2.e1" e2="DrugDDI.d396.s2.e6" interaction="true"/><pair id="DrugDDI.d396.s2.p11" e1="DrugDDI.d396.s2.e2" e2="DrugDDI.d396.s2.e3" interaction="false"/><pair id="DrugDDI.d396.s2.p12" e1="DrugDDI.d396.s2.e2" e2="DrugDDI.d396.s2.e4" interaction="false"/><pair id="DrugDDI.d396.s2.p13" e1="DrugDDI.d396.s2.e2" e2="DrugDDI.d396.s2.e5" interaction="false"/><pair id="DrugDDI.d396.s2.p14" e1="DrugDDI.d396.s2.e2" e2="DrugDDI.d396.s2.e6" interaction="true"/><pair id="DrugDDI.d396.s2.p15" e1="DrugDDI.d396.s2.e3" e2="DrugDDI.d396.s2.e4" interaction="false"/><pair id="DrugDDI.d396.s2.p16" e1="DrugDDI.d396.s2.e3" e2="DrugDDI.d396.s2.e5" interaction="false"/><pair id="DrugDDI.d396.s2.p17" e1="DrugDDI.d396.s2.e3" e2="DrugDDI.d396.s2.e6" interaction="true"/><pair id="DrugDDI.d396.s2.p18" e1="DrugDDI.d396.s2.e4" e2="DrugDDI.d396.s2.e5" interaction="false"/><pair id="DrugDDI.d396.s2.p19" e1="DrugDDI.d396.s2.e4" e2="DrugDDI.d396.s2.e6" interaction="true"/><pair id="DrugDDI.d396.s2.p20" e1="DrugDDI.d396.s2.e5" e2="DrugDDI.d396.s2.e6" interaction="true"/></sentence><sentence id="DrugDDI.d396.s3" origId="s3" text="Dose modification is recommended for patients who are also receiving a potent CYP 3A4 inducer."><entity id="DrugDDI.d396.s3.e0" origId="s3.p43" charOffset="78-81" type="drug" text="CYP"/></sentence><sentence id="DrugDDI.d396.s4" origId="s4" text="Drug/Laboratory Tests Interactions No clinically relevant changes in the results of clinical laboratory tests have been observed."><entity id="DrugDDI.d396.s4.e0" origId="s4.p44" charOffset="0-4" type="drug" text="Drug"/></sentence></document>